Cover Image
Market Research Report
Product code
1008629

Placental Stem Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Published: | Transparency Market Research | 165 Pages | Delivery time: 1-2 business days

Price

Back to Top
Placental Stem Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030
Published: March 2, 2021
Transparency Market Research
Content info: 165 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

Scope of the Report

TMR's report on the global placental stem cell therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2020 to 2030. The report provides revenue of the global placental stem cell therapy market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global placental stem cell therapy market from 2020 to 2030.

The report has been prepared after an extensive primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the placental stem cell therapy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the placental stem cell therapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global placental stem cell therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global placental stem cell therapy market.

The report delves into the competition landscape of the global placental stem cell therapy market. Key players operating in the global placental stem cell therapy market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global placental stem cell therapy market profiled in this report.

Key Questions Answered:

  • What is the sales/revenue generated by the placental stem cell therapy market across all regions during the forecast period?
  • What are the opportunities in the global placental stem cell therapy market?
  • What are major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which drug class segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Research Objectives and Research Approach

The comprehensive report on the global placental stem cell therapy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of objectives behind this study, and key vendors and distributors operating in the market and regulatory scenario for approval of the products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global placental stem cell therapy market in terms of application, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global placental stem cell therapy market.

Table of Contents
Product Code: TMRGL81612

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Placental Stem Cell Therapy Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Application Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Placental Stem Cell Therapy Market Analysis and Forecast, 2018-2030
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Supply Chain Analysis
    • 5.1.1. Placental Stem Cells Collection & Isolation
    • 5.1.2. Cell processing & Cryo-preservation
    • 5.1.3. Cell Differentiation
    • 5.1.4. Cell Culture and Expansion
  • 5.2. Pipeline Analysis
  • 5.3. Regulatory Scenario, by Region/globally
  • 5.4. Reimbursement Scenario, by Region/globally
  • 5.5. Pricing Analysis, 2019
  • 5.6. COVID-19 Pandemic Impact on Industry

6. Global Placental Stem Cell Therapy Market Analysis and Forecast, by Application

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global Placental Stem Cell Therapy Market Value Forecast, by Application, 2018-2030
    • 6.3.1. Hematologic Malignancies and Disorders
    • 6.3.2. Congenital Immunodeficiency Disorders
    • 6.3.3. Metabolic Disorders
    • 6.3.4. Neurological Disorders
    • 6.3.5. Others
  • 6.4. Global Placental Stem Cell Therapy Market Attractiveness Analysis, by Application

7. Global Placental Stem Cell Therapy Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Global Placental Stem Cell Therapy Market Value Forecast, by End-user, 2018-2030
    • 7.3.1. Hospitals & Specialty Clinics
    • 7.3.2. Clinical Research Organizations
    • 7.3.3. Research Institutes & Academies
  • 7.4. Global Placental Stem Cell Therapy Market Attractiveness Analysis, by End-user

8. Global Placental Stem Cell Therapy Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Global Placental Stem Cell Therapy Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Global Placental Stem Cell Therapy Market Attractiveness Analysis, by Country/Region

9. North America Placental Stem Cell Therapy Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. North America Placental Stem Cell Therapy Market Value Forecast, by Application, 2018-2030
    • 9.2.1. Hematologic Malignancies and Disorders
    • 9.2.2. Congenital Immunodeficiency Disorders
    • 9.2.3. Metabolic Disorders
    • 9.2.4. Neurological Disorders
    • 9.2.5. Others
  • 9.3. North America Placental Stem Cell Therapy Market Value Forecast, by End-user, 2018-2030
    • 9.3.1. Hospitals & Specialty Clinics
    • 9.3.2. Clinical Research Organizations
    • 9.3.3. Research Institutes & Academies
  • 9.4. North America Placental Stem Cell Therapy Market Value Forecast, by Country, 2018-2030
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. North America Placental Stem Cell Therapy Market Attractiveness Analysis
    • 9.5.1. By Application
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Placental Stem Cell Therapy Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Europe Placental Stem Cell Therapy Market Value Forecast, by Application, 2018-2030
    • 10.2.1. Hematologic Malignancies and Disorders
    • 10.2.2. Congenital Immunodeficiency Disorders
    • 10.2.3. Metabolic Disorders
    • 10.2.4. Neurological Disorders
    • 10.2.5. Others
  • 10.3. Europe Placental Stem Cell Therapy Market Value Forecast, by End-user, 2018-2030
    • 10.3.1. Hospitals & Specialty Clinics
    • 10.3.2. Clinical Research Organizations
    • 10.3.3. Research Institutes & Academies
  • 10.4. Europe Placental Stem Cell Therapy Market Value Forecast, by Country/Sub-region, 2018-2030
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Europe Placental Stem Cell Therapy Market Attractiveness Analysis
    • 10.5.1. By Application
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Placental Stem Cell Therapy Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Asia Pacific Placental Stem Cell Therapy Market Value Forecast, by Application, 2018-2030
    • 11.2.1. Hematologic Malignancies and Disorders
    • 11.2.2. Congenital Immunodeficiency Disorders
    • 11.2.3. Metabolic Disorders
    • 11.2.4. Neurological Disorders
    • 11.2.5. Others
  • 11.3. Asia Pacific Placental Stem Cell Therapy Market Value Forecast, by End-user, 2018-2030
    • 11.3.1. Hospitals & Specialty Clinics
    • 11.3.2. Clinical Research Organizations
    • 11.3.3. Research Institutes & Academies
  • 11.4. Asia Pacific Placental Stem Cell Therapy Market Value Forecast, by Country/Sub-region, 2018-2030
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Asia Pacific Placental Stem Cell Therapy Market Attractiveness Analysis
    • 11.5.1. By Application
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Placental Stem Cell Therapy Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Latin America Placental Stem Cell Therapy Market Value Forecast, by Application, 2018-2030
    • 12.2.1. Hematologic Malignancies and Disorders
    • 12.2.2. Congenital Immunodeficiency Disorders
    • 12.2.3. Metabolic Disorders
    • 12.2.4. Neurological Disorders
    • 12.2.5. Others
  • 12.3. Latin America Placental Stem Cell Therapy Market Value Forecast, by End-user, 2018-2030
    • 12.3.1. Hospitals & Specialty Clinics
    • 12.3.2. Clinical Research Organizations
    • 12.3.3. Research Institutes & Academies
  • 12.4. Latin America Placental Stem Cell Therapy Market Value Forecast, by Country/Sub-region, 2018-2030
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Latin America Placental Stem Cell Therapy Market Attractiveness Analysis
    • 12.5.1. By Application
    • 12.5.2. By End-user
    • 12.5.3. By Country//Sub-region

13. Middle East & Africa Placental Stem Cell Therapy Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Middle East & Africa Placental Stem Cell Therapy Market Value Forecast, by Application, 2018-2030
    • 13.2.1. Hematologic Malignancies and Disorders
    • 13.2.2. Congenital Immunodeficiency Disorders
    • 13.2.3. Metabolic Disorders
    • 13.2.4. Neurological Disorders
    • 13.2.5. Others
  • 13.3. Middle East & Africa Placental Stem Cell Therapy Market Value Forecast, by End-user, 2018-2030
    • 13.3.1. Hospitals & Specialty Clinics
    • 13.3.2. Clinical Research Organizations
    • 13.3.3. Research Institutes & Academies
  • 13.4. Middle East & Africa Placental Stem Cell Therapy Market Value Forecast, by Country/Sub-region, 2018-2030
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Middle East & Africa Placental Stem Cell Therapy Market Attractiveness Analysis
    • 13.5.1. By Application
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis, by Company, 2019
  • 14.3. Company Profiles
    • 14.3.1. Lifebank Stem Cell Banking
      • 14.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. SWOT Analysis
      • 14.3.1.4. Strategic Overview
    • 14.3.2. Celularity, Inc.
      • 14.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. SWOT Analysis
      • 14.3.2.4. Strategic Overview
    • 14.3.3. Americord Registry
      • 14.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. SWOT Analysis
      • 14.3.3.4. Strategic Overview
    • 14.3.4. ReeLabs Pvt. Ltd.
      • 14.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. SWOT Analysis
      • 14.3.4.4. Strategic Overview
    • 14.3.5. Pluristem Therapeutics, Inc.
      • 14.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. SWOT Analysis
      • 14.3.5.4. Strategic Overview
    • 14.3.6. Mesoblast Limited
      • 14.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. SWOT Analysis
      • 14.3.6.4. Strategic Overview
    • 14.3.7. ReNeuron Group plc
      • 14.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. SWOT Analysis
      • 14.3.7.4. Strategic Overview
    • 14.3.8. Athersys, Inc.
      • 14.3.8.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. SWOT Analysis
      • 14.3.8.4. Strategic Overview
    • 14.3.9. Other Prominent Key Players

List of Tables

  • Table 1: Global Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 2: Global Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2018-2030
  • Table 3: Global Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Region, 2018-2030
  • Table 4: North America Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Country, 2018-2030
  • Table 5: North America Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 6: North America Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2018-2030
  • Table 7: Europe Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Country, 2018-2030
  • Table 8: Europe Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 9: Europe Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2018-2030
  • Table 10: Asia Pacific Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Country, 2018-2030
  • Table 11: Asia Pacific Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 12: Asia Pacific Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2018-2030
  • Table 13: Latin America Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Country, 2018-2030
  • Table 14: Latin America Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 15: Latin America Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2018-2030
  • Table 16: Middle East & Africa Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Country, 2018-2030
  • Table 17: Middle East & Africa Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 18: Middle East & Africa Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2018-2030

List of Figures

  • Figure 1: Global Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 2: Global Placental Stem Cell Therapy Market Value Share, by Application (2019)
  • Figure 3: Global Placental Stem Cell Therapy Market Value Share, by End-user (2019)
  • Figure 4: Global Placental Stem Cell Therapy Market Value Share, by Region (2019)
  • Figure 5: Global Placental Stem Cell Therapy Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 6: Global Placental Stem Cell Therapy Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 7: Global Placental Stem Cell Therapy Market Value (US$ Mn), by Hematologic Malignancies and Disorders, 2018-2030
  • Figure 8: Global Placental Stem Cell Therapy Market Value (US$ Mn), by Congenital Immunodeficiency Disorders, 2018-2030
  • Figure 9: Global Placental Stem Cell Therapy Market Value (US$ Mn), by Metabolic Disorders, 2018-2030
  • Figure 10: Global Placental Stem Cell Therapy Market Value (US$ Mn), by Neurological Disorders, 2018-2030
  • Figure 11: Global Placental Stem Cell Therapy Market Value (US$ Mn), by Others, 2018-2030
  • Figure 12: Global Placental Stem Cell Therapy Market Value Share Analysis, by End-user, 2019 and 2030
  • Figure 13: Global Placental Stem Cell Therapy Market attractiveness index Analysis, by End-user, 2020-2030
  • Figure 14: Global Placental Stem Cell Therapy Market Value (US$ Mn), by Hospitals & Specialty Clinics, 2018-2030
  • Figure 15: Global Placental Stem Cell Therapy Market Value (US$ Mn), by Clinical Research Organizations, 2018-2030
  • Figure 16: Global Placental Stem Cell Therapy Market Value (US$ Mn), by Research Institutes & Academies, 2018-2030
  • Figure 17: Global Placental Stem Cell Therapy Market Value Share Analysis, by Region, 2019 and 2030
  • Figure 18: Global Placental Stem Cell Therapy Market Attractiveness Analysis, by Region, 2020-2030
  • Figure 19: North America Placental Stem Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 20: North America Placental Stem Cell Therapy Market Value Share, by Country, 2019-2030
  • Figure 21: North America Placental Stem Cell Therapy Market Attractiveness, by Country, 2019-2030
  • Figure 22: North America Placental Stem Cell Therapy Market Value Share (%), by Application, 2019 and 2030
  • Figure 23: North America Placental Stem Cell Therapy Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 24: North America Placental Stem Cell Therapy Market Value Share (%), by End-user, 2019 and 2030
  • Figure 25: North America Placental Stem Cell Therapy Market Attractiveness Analysis, by End-user, 2020-2030
  • Figure 26: Europe Placental Stem Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 27: Europe Placental Stem Cell Therapy Market Value Share, by Country, 2019-2030
  • Figure 28: Europe Placental Stem Cell Therapy Market Attractiveness, by Country, 2019-2030
  • Figure 29: Europe Placental Stem Cell Therapy Market Value Share (%), by Application, 2019 and 2030
  • Figure 30: Europe Placental Stem Cell Therapy Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 31: Europe Placental Stem Cell Therapy Market Value Share (%), by End-user, 2019 and 2030
  • Figure 32: Europe Placental Stem Cell Therapy Market Attractiveness Analysis, by End-user, 2020-2030
  • Figure 33: Asia Pacific Placental Stem Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 34: Asia Pacific Placental Stem Cell Therapy Market Value Share, by Country, 2019-2030
  • Figure 35: Asia Pacific Placental Stem Cell Therapy Market Attractiveness, by Country, 2019-2030
  • Figure 36: Asia Pacific Placental Stem Cell Therapy Market Value Share (%), by Application, 2019 and 2030
  • Figure 37: Asia Pacific Placental Stem Cell Therapy Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 38: Asia Pacific Placental Stem Cell Therapy Market Value Share (%), by End-user, 2019 and 2030
  • Figure 39: Asia Pacific Placental Stem Cell Therapy Market Attractiveness Analysis, by End-user, 2020-2030
  • Figure 40: Latin America Placental Stem Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 41: Latin America Placental Stem Cell Therapy Market Value Share, by Country, 2019-2030
  • Figure 42: Latin America Placental Stem Cell Therapy Market Attractiveness, by Country, 2019-2030
  • Figure 43: Latin America Placental Stem Cell Therapy Market Value Share (%), by Application, 2019 and 2030
  • Figure 44: Latin America Placental Stem Cell Therapy Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 45: Latin America Placental Stem Cell Therapy Market Value Share (%), by End-user, 2019 and 2030
  • Figure 46: Latin America Placental Stem Cell Therapy Market Attractiveness Analysis, by End-user, 2020-2030
  • Figure 47: Middle East Africa Placental Stem Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 48: Middle East Africa Placental Stem Cell Therapy Market Value Share, by Country, 2019-2030
  • Figure 49: Middle East Africa Placental Stem Cell Therapy Market Attractiveness, by Country, 2019-2030
  • Figure 50: Middle East Africa Placental Stem Cell Therapy Market Value Share (%), by Application, 2019 and 2030
  • Figure 51: Middle East Africa Placental Stem Cell Therapy Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 52: Middle East Africa Placental Stem Cell Therapy Market Value Share (%), by End-user, 2019 and 2030
  • Figure 53: Middle East Africa Placental Stem Cell Therapy Market Attractiveness Analysis, by End-user, 2020-2030
  • Figure 54: Market Position Analysis, 2018, by Tier and Size of the Company